论文部分内容阅读
我们通过检测进展期胃癌患者在应用低剂量乙胺甲酰氟脲嘧啶（HcFu）诱导化疗前后的NK、LAK和IL－2活性变化，旨在了解HcFU对胃癌患者IL－2，NK和LAK活性的影响。1．材料与方法（1）对象：对照组（正常健康人）20人，其中男12人，女8人，平均年龄42.4±12.4岁。胃癌组，共30人，
We examined the activity of NK, LAK and IL-2 before and after induction of chemotherapy with low-dose carbamoylfluorouracil (HcFu) in patients with advanced gastric cancer in order to understand the activity of HcFU on IL-2, NK and LAK in gastric cancer patients. Impact. 1. Materials and Methods (1) Subjects: There were 20 control subjects (normal healthy subjects), including 12 males and 8 females, with an average age of 42.4±12.4 years. Gastric cancer group, a total of 30 people,